ENFERMEDADES REUMÁTICAS
GlaxoSmithKline (Spain)
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von GlaxoSmithKline (Spain) (1)
2019
-
Budget impact analysis of subcutaneous belimumab in patients with systemic lupus erythematosus in Spain
ClinicoEconomics and Outcomes Research, Vol. 11, pp. 757-765